Evidence map›Paper›PMID 20164218›Full record

ArticleJournal of virology2010

Human T-lymphotropic virus type 1 transcription and chromatin-remodeling complexes.

Rebecca Easley, Lawrence Carpio, Irene Guendel, Zachary Klase, Soyun Choi, Kylene Kehn-Hall, John N Brady, Fatah Kashanchi

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Mechanisms of Oncogenesis by HTLV-1 Tax.Pathogens (Basel, Switzerland) · 2020
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Rebecca EasleyDepartment of Microbiology, Immunology, and Tropical Medicine, The George Washington University, 2300 I St., NW, Ross Hall, Room 551, Washington, DC 20037, USA.
Lawrence Carpio
Irene Guendel
Zachary Klase
Soyun Choi
Kylene Kehn-Hall
John N Brady
Fatah Kashanchi
George Washington University · USGeorge Mason University · USNational Cancer Institute · USNational Institute of Allergy and Infectious Diseases · US

Funding

HIV1 INHIBITION USING TAT PEPTIDE DERIVATIVESR01AI043894 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KASHANCHI, FATAH · 1999 to 2015
$4.4M
Regulation of CMV Immediate Early Gene ExpressionR01AI046459 · NIAID · CHILDREN'S RESEARCH INSTITUTE · PI COLBERG POLEY, ANAMARIS MARTHA · 2001 to 2004
$1.1M
CELL CYCLE REGULATED TRANSCRIPTION BY HIV1 TRANSACT TATR29AI044357 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KASHANCHI, FATAH · 1998 to 2002
$322k
NIAID NIH HHS AI43894NIAID NIH HHS AI44357NIAID NIH HHS AI46459NIAID NIH HHS R01 AI043894NIAID NIH HHS R01 AI046459NIAID NIH HHS R29 AI044357
6 · The paper itself

Abstract

Human T-lymphotropic virus type 1 (HTLV-1) encodes the viral protein Tax, which is believed to act as a viral transactivator through its interactions with a variety of transcription factors, including CREB and NF-kappaB. As is the case for all retroviruses, the provirus is inserted into the host DNA, where nucleosomes are deposited to ensure efficient packaging. Nucleosomes act as roadblocks in transcription, making it difficult for RNA polymerase II (Pol II) to proceed toward the 3' end of the genome. Because of this, a variety of chromatin remodelers can act to modify nucleosomes, allowing for efficient transcription. While a number of covalent modifications are known to occur on histone tails in HTLV-1 infection (i.e., histone acetyltransferases [HATs], histone deacetylases [HDACs], and histone methyltransferases [HMTs]), evidence points to the use of chromatin remodelers that use energy from ATP hydrolysis to remodel nucleosomes. Here we confirm that BRG1, which is the core subunit of eight chromatin-remodeling complexes, is essential not only for Tax transactivation but also for viral replication. This is especially evident when wild-type infectious clones of HTLV-1 are used. BRG1 associates with Tax at the HTLV-1 long terminal repeat (LTR), and coexpression of BRG1 and Tax results in increased rates of transcription. The interaction of BRG1 with Tax additionally recruits the basal transcriptional machinery and removes some of the core histones from the nucleosome at the start site (Nuc 1). When using the BRG1-deficient cell lines SW13, C33A, and TSUPR1, we observed little viral transcription and no viral replication. Importantly, while these three cell lines do not express detectable levels of BRG1, much of the SWI/SNF complex remains assembled in the cells. Knockdown of BRG1 and associated SWI/SNF subunits suggests that the BRG1-utilizing SWI/SNF complex PBAF is responsible for HTLV-1 nucleosome remodeling. Finally, HTLV-1 infection of cell lines with a knockdown in BRG1 or the PBAF complex results in a significant reduction in viral production. Overall, we concluded that BRG1 is required for Tax transactivation and HTLV-1 viral production and that the PBAF complex appears to be responsible for nucleosome remodeling.

Indexed as

Chromatin Assembly and DisassemblyTranscription, GeneticVirus ReplicationCell LineDNA HelicasesDNA, ViralGene Products, taxHumansHuman T-lymphotropic virus 1Nuclear ProteinsProtein BindingProtein Interaction MappingTerminal Repeat SequencesTranscription FactorsDNA HelicasesDNA, ViralGene Products, taxNuclear ProteinsSMARCA4 protein, humantax protein, Human T-lymphotrophic virus 1Transcription Factors

Identifiers

PMID20164218
PMCPMC2863730
OpenAlexW1967802133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.